6095 — MedPeer Income Statement

0.000.00%

Last trade - 00:00

TechnologySpeculativeSmall CapSuper Stock

Annual income statement for MedPeer, fiscal year end - September 30th, JPY millions except per share, conversion factor applied.

	2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	5,311	7,435	8,452	14,541	14,948
Cost of Revenue
Gross Profit	3,506	4,855	5,034	6,867	6,872
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	4,206	5,652	7,388	13,538	12,596
Operating Profit	1,105	1,784	1,064	1,002	2,353
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,131	1,812	1,114	1,047	2,372
Provision for Income Taxes
Net Income After Taxes	803	1,332	815	638	1,500
Minority Interest
Net Income Before Extraordinary Items
Net Income	726	1,293	812	618	1,482
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	726	1,293	812	618	1,482
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	34.5	57.9	37.9	45.3	50.6
Dividends per Share